Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Diametrics Medical

This article was originally published in The Gray Sheet

Executive Summary

Announces that underwriters Hambrecht & Quist and Vector Securities International have exercised their option to purchase 375,000 overallotment shares of Diametrics Medical common stock. The Minneapolis-based blood chemistry diagnostic company recently netted $14 mil. in its initial public offering of 2.5 mil. shares ("The Gray Sheet" July 4, p. 33). The overallotment purchase will provide an additional $2.1 mil., bringing the total net proceeds from the offering to $16.1 mil

Latest Headlines
See All
UsernamePublicRestriction

Register

MT002574

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel